Spirocyclic EBI2 modulators
US10196369B2 · kind B2 · utility
4Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2014 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Sep 26, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/650952
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are small molecule Epstein-Barr virus-induced G-protein coupled receptor 2 (EBI2) modulator compounds, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds. In some embodiments, EBI2 is a therapeutic target for the treatment of diseases or conditions such as, but not limited to, autoimmune diseases or conditions, cancer, and cardiovascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.